Agilon Health (NYSE:AGL – Get Free Report) is anticipated to issue its Q2 2025 quarterly earnings data after the market closes on Tuesday, August 5th. Analysts expect the company to announce earnings of ($0.11) per share and revenue of $1.47 billion for the quarter. Agilon Health has set its FY 2025 guidance at EPS and its Q2 2025 guidance at EPS.
Agilon Health (NYSE:AGL – Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported $0.03 EPS for the quarter, topping the consensus estimate of ($0.01) by $0.04. Agilon Health had a negative return on equity of 45.47% and a negative net margin of 4.04%. The business had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.50 billion. During the same quarter in the previous year, the firm posted ($0.02) earnings per share. The company’s revenue was down 4.5% compared to the same quarter last year. On average, analysts expect Agilon Health to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Agilon Health Stock Performance
NYSE:AGL opened at $1.70 on Friday. Agilon Health has a one year low of $1.50 and a one year high of $6.63. The business’s 50-day simple moving average is $2.20 and its 200 day simple moving average is $3.22. The stock has a market cap of $701.65 million, a price-to-earnings ratio of -2.87 and a beta of 0.14.
Hedge Funds Weigh In On Agilon Health
Analysts Set New Price Targets
AGL has been the topic of several recent analyst reports. Sanford C. Bernstein upgraded Agilon Health from a “market perform” rating to an “outperform” rating and boosted their price target for the stock from $3.30 to $8.50 in a research note on Tuesday, April 8th. Wells Fargo & Company cut their price target on Agilon Health from $6.00 to $5.00 and set an “overweight” rating on the stock in a research note on Tuesday, May 13th. Evercore ISI decreased their price target on Agilon Health from $5.00 to $3.00 and set an “in-line” rating for the company in a research note on Wednesday, July 9th. Robert W. Baird decreased their price target on Agilon Health from $6.00 to $5.00 and set a “neutral” rating for the company in a research note on Tuesday, April 15th. Finally, JMP Securities reiterated a “market perform” rating on shares of Agilon Health in a research note on Monday, April 28th. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, Agilon Health presently has a consensus rating of “Hold” and a consensus target price of $4.71.
Check Out Our Latest Research Report on Agilon Health
Agilon Health Company Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Articles
- Five stocks we like better than Agilon Health
- Why Are These Companies Considered Blue Chips?
- Bitcoin and Dividends: A Winning Combo in These 3 ETFs
- What is the Shanghai Stock Exchange Composite Index?
- Is PG&E an AI Power Play? Why Options Traders Are Betting Big
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- MarketBeat Week in Review – 07/28 – 08/01
Receive News & Ratings for Agilon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health and related companies with MarketBeat.com's FREE daily email newsletter.